🔎 Trials Near Me

Home › Langerhans Cell Histiocytosis › Texas

Pag-aaral pangklinika para sa Langerhans Cell Histiocytosis sa Texas

4 pag-aaral para sa Langerhans Cell Histiocytosis ang naghahanap ng mga kalahok sa mga site sa Texas.

Mga Lungsod sa Texas

Opisyal na teksto ng pag-aaral (English)

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

  • Dell Children's Medical Center of Central Texas, Austin
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
  • El Paso Children's Hospital, El Paso
  • at 6 pa
Nagre-recruitPhase 2
180 Days – 22 Years · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05828069

Targeted Approach to Langerhans Cell Histiocytosis (LCH) Using MEK Inhibitor, Trametinib

  • Cook Children's Health Care System, Fort Worth
Nagre-recruitPhase 2
Edad 1 hanggang 30 · Lahat ng kasarian · Na-update Abr 7, 2026 · NCT06582745

Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders

  • Children's Medical Center- UTSW, Dallas
  • Texas Children's Hospital, Houston
Nagre-recruitPhase 2
Lahat ng edad · Lahat ng kasarian · Na-update Set 18, 2025 · NCT04079179

Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)

  • Dell Children's Medical Center, Austin
  • Cook Children's Health Care System, Fort Worth
  • Texas Children's Hospital, Houston
  • at 2 pa
Nagre-recruitPhase 3
Hanggang edad 21 · Lahat ng kasarian · Na-update Set 11, 2025 · NCT02670707

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.